Glucose-6-phosphate dehydrogenase deficiency and the risk of malaria and other diseases in children in Kenya: A case-control and a cohort study

The Lancet Haematology

Volumn 2, Issue 10, 2015, Pages e437-e444

  Uyoga, Sophie ^a   Ndila, Carolyne M ^a,b   Macharia, Alex W ^a   Nyutu, Gideon ^a   Shah, Shivang ^b,c   Peshu, Norbert ^a   Clarke, Geraldine M ^b   Kwiatkowski, Dominic P ^b,d   Rockett, Kirk A ^b   Williams, Thomas N ^a,e  

^a KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA THALASSEMIA; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISTASIS; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PRIORITY JOURNAL; RESPIRATORY DISTRESS; ADOLESCENT; COMPLICATION; HETEROZYGOTE; INFANT; MALARIA; MALE; PRESCHOOL CHILD; RISK FACTOR; UNITED STATES;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HUMANS; INFANT; KENYA; MALARIA; MALE; RISK FACTORS; UNITED STATES;

EID: 84955695298     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(15)00152-0     Document Type: Article

References (42)

1. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008; 371: 64-74.
2. Minucci A, Moradkhani K, Hwang MJ, et al. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the 'old' and update of the new mutations. Blood Cells Mol Dis 2012; 48: 154-65.
3. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med 1998; 76: 581-88.
4. Luzzatto L. G6PD deficiency and malaria selection. Heredity (Edinb) 2012; 108: 456.
5. Shah SS, Macharia A, Makale J, et al. Genetic determinants of glucose-6-phosphate dehydrogenase activity in Kenya. BMC Med Genet 2014; 15: 93.
6. Scott JA, Bauni E, Moisi JC, et al. Profile: The KilifiHealth and Demographic Surveillance System (KHDSS). Int J Epidemiol 2012; 41: 650-57.
7. The Malaria Genomic Epidemiology Network. Reappraisal of known malaria resistance loci in a large multicenter study. Nat Genet 2014; 46: 1197-204.
8. Williams TN, Uyoga S, Macharia A, et al. Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study. Lancet 2009; 374: 1364-70.
9. Williams TN, Mwangi TW, Wambua S, et al. Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases. J Infect Dis 2005; 192: 178-86.
10. Williams TN, Wambua S, Uyoga S, et al. Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal Plasmodium falciparum malaria on the coast of Kenya. Blood 2005; 106: 368-71.
11. Guindo A, Traore K, Diakite S, Wellems TE, Doumbo OK, Diallo DA. An evaluation of concurrent G6PD (A-) deficiency and sickle cell trait in Malian populations of children with severe or uncomplicated P. falciparum malaria. Am J Hematol 2011; 86: 795-96.
12. Siniscalco M, Bernini L, Filippi G, et al. Population genetics of haemoglobin variants, thalassaemia and glucose-6-phosphate dehydrogenase deficiency, with particular reference to the malaria hypothesis. Bull World Health Organ 1966; 34: 379-93.
13. Siniscalco M, Bernini L, Latte B. Favism and thalassaemia in Sardinia and their relationship to malaria. Nature 1961; 190: 1179-80.
14. Samuel AP, Saha N, Acquaye JK, Omer A, Ganeshaguru K, Hassounh E. Association of red cell glucose-6-phosphate dehydrogenase with haemoglobinopathies. Hum Hered 1986; 36: 107-12.
15. Williams TN, Mwangi TW, Wambua S, et al. Negative epistasis between the malaria-protective effects of a+-thalassemia and the sickle cell trait. Nat Genet 2005; 37: 1253-57.
16. Luzzatto L, Seneca E. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications. Br J Haematol 2014; 164: 469-80.
17. Howes RE, Piel FB, Patil AP, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 2012; 9: e1001339.
18. Sirugo G. Reassessing an old claim: natural selection of hemizygotes and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Am J Hematol 2013; 88: 436.
19. Ruwende C, Khoo SC, Snow RW, et al. Natural selection of hemi-and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Nature 1995; 376: 246-49.
20. Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with nondeficient variant. Lancet 1972; 299: 107-10.
21. Luzzatto L, Usanga FA, Reddy S. Glucose-6-phosphate dehydrogenase deficient red cells: resistance to infection by malarial parasites. Science 1969; 164: 839-42.
22. Mockenhaupt FP, Mandelkow J, Till H, Ehrhardt S, Eggelte TA, Bienzle U. Reduced prevalence of Plasmodium falciparum infection and of concomitant anaemia in pregnant women with heterozygous G6PD deficiency. Trop Med Int Health 2003; 8: 118-24.
23. Sirugo G, Predazzi IM, Bartlett J, Tacconelli A, Walther M, Williams SM. G6PD A-deficiency and severe malaria in The Gambia: heterozygote advantage and possible homozygote disadvantage. Am J Trop Med Hyg 2014; 90: 856-59.
24. Manjurano A, Sepulveda N, Nadjm B, et al. African glucose-6-phosphate dehydrogenase alleles associated with protection from severe malaria in heterozygous females in Tanzania. PLoS Genet 2015; 11: e1004960.
25. Powell RD, Brewer GJ, DeGowin RL, Carson PE. Effects of glucose-6-phosphate dehydrogenase deficiency upon the host and upon host-drug-malaria parasite interactions. Mil Med 1966;131(suppl):1039-56.
26. Martin SK, Miller LH, Alling D, et al. Severe malaria and glucose-6-phosphate-dehydrogenase deficiency: a reappraisal of the malaria/G-6-P.D. hypothesis. Lancet 1979; 313: 524-26.
27. Guindo A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med 2007; 4: e66.
28. Suchdev PS, Ruth LJ, Earley M, Macharia A, Williams TN. The burden and consequences of inherited blood disorders among young children in western Kenya. Matern Child Nutr 2014; 10: 135-44.
29. Louicharoen C, Patin E, Paul R, et al. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Science 2009; 326: 1546-49.
30. Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S. Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS One 2009; 4: e7246.
31. Battistuzzi G, Esan GJ, Fasuan FA, Modiano G, Luzzatto L. Comparison of GdA and GdB activities in Nigerians. A study of the variation of the G6PD activity. Am J Hum Genet 1977; 29: 31-36.
32. Clark TG, Fry AE, Auburn S, et al. Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet 2009; 17: 1080-85.
33. De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R. The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the Seerer population of Senegal. Haematologica 2006; 91: 262-63.
34. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA for human glucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci USA 1988; 85: 3951-54.
35. Pamba A, Richardson ND, Carter N, et al. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone. Blood 2012; 120: 4123-33.
36. O'Meara WP, Bejon P, Mwangi TW, et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 2008; 372: 1555-62.
37. Min-Oo G, Gros P. Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol 2005; 7: 753-63.
38. Allison AC, Clyde DF. Malaria in African children with deficient erythrocyte glucose-6-phosphate dehydrogenase. BMJ 1961; 1: 1346-49.
39. Lopera-Mesa TM, Doumbia S, Konaté D, et al. Effect of red blood cell variants on childhood malaria in Mali: a prospective cohort study. Lancet Haematol 2015; 2: e140-49.
40. Mombo LE, Ntoumi F, Bisseye C, et al. Human genetic polymorphisms and asymptomatic Plasmodium falciparum malaria in Gabonese schoolchildren. Am J Trop Med Hyg 2003; 68: 186-90.
41. Bernstein SC, Bowman JE, Kaptue Noche L. Population studies in Cameroon: hemoglobin S, glucose-6-phosphate dehydrogenase deficiency and falciparum malaria. Hum Hered 1980; 30: 251-58.
42. Cappadoro M, Giribaldi G, O'Brien E, et al. Early phagocytosis of G6PD deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998; 92: 2527-34.